CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 784 of 865
Non-Antibody Products
Page 784 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Taraxasterol Acetate | A pentacyclic triterpene with diverse biological activities; reduces PMA-i… | 1 mg | 36131-1 | More Info |
| Taraxasterol Acetate | A pentacyclic triterpene with diverse biological activities; reduces PMA-i… | 10 mg | 36131-10 | More Info |
| Taraxasterol Acetate | A pentacyclic triterpene with diverse biological activities; reduces PMA-i… | 25 mg | 36131-25 | More Info |
| Taraxasterol Acetate | A pentacyclic triterpene with diverse biological activities; reduces PMA-i… | 5 mg | 36131-5 | More Info |
| Targeted Lipid Analysis | Our lipid experts offer targeted lipid analysis services to analyze lipid… | n/a | n/a | More Info |
| Tariquidar | A P-gp inhibitor; binds to P-glycoprotein (Kd = 5.1 nM); inhibits transpor… | 10 mg | 24180-10 | More Info |
| Tariquidar | A P-gp inhibitor; binds to P-glycoprotein (Kd = 5.1 nM); inhibits transpor… | 100 mg | 24180-100 | More Info |
| Tariquidar | A P-gp inhibitor; binds to P-glycoprotein (Kd = 5.1 nM); inhibits transpor… | 25 mg | 24180-25 | More Info |
| Tariquidar | A P-gp inhibitor; binds to P-glycoprotein (Kd = 5.1 nM); inhibits transpor… | 5 mg | 24180-5 | More Info |
| TAS 0728 | A covalent HER2 inhibitor (IC50 = 36 nM); selective for HER2 over panels o… | 1 mg | 33528-1 | More Info |
| TAS 0728 | A covalent HER2 inhibitor (IC50 = 36 nM); selective for HER2 over panels o… | 10 mg | 33528-10 | More Info |
| TAS 0728 | A covalent HER2 inhibitor (IC50 = 36 nM); selective for HER2 over panels o… | 25 mg | 33528-25 | More Info |
| TAS 0728 | A covalent HER2 inhibitor (IC50 = 36 nM); selective for HER2 over panels o… | 5 mg | 33528-5 | More Info |
| TAS 102 | An orally bioavailable combination of the antimetabolite nucleoside analog… | 10 mg | 23932-10 | More Info |
| TAS 102 | An orally bioavailable combination of the antimetabolite nucleoside analog… | 25 mg | 23932-25 | More Info |
| TAS 102 | An orally bioavailable combination of the antimetabolite nucleoside analog… | 5 mg | 23932-5 | More Info |
| TAS 102 | An orally bioavailable combination of the antimetabolite nucleoside analog… | 50 mg | 23932-50 | More Info |
| TAS 116 | An Hsp90 inhibitor; selectively binds to Hsp90α and Hsp90β (Kis… | 10 mg | 33779-10 | More Info |
| TAS 116 | An Hsp90 inhibitor; selectively binds to Hsp90α and Hsp90β (Kis… | 25 mg | 33779-25 | More Info |
| TAS 116 | An Hsp90 inhibitor; selectively binds to Hsp90α and Hsp90β (Kis… | 5 mg | 33779-5 | More Info |
| TAS 120 | An orally bioavailable inhibitor of FGFRs that irreversibly inhibits all f… | 1 mg | 21136-1 | More Info |
| TAS 120 | An orally bioavailable inhibitor of FGFRs that irreversibly inhibits all f… | 10 mg | 21136-10 | More Info |
| TAS 120 | An orally bioavailable inhibitor of FGFRs that irreversibly inhibits all f… | 5 mg | 21136-5 | More Info |
| TAS 120 | An orally bioavailable inhibitor of FGFRs that irreversibly inhibits all f… | 500 µg | 21136-500 | More Info |
| TAS 205 | An inhibitor of H-PGDS (IC50 = 55.8 nM); selective for H-PGDS over L-PGDS… | 1 mg | 33261-1 | More Info |
| TAS 205 | An inhibitor of H-PGDS (IC50 = 55.8 nM); selective for H-PGDS over L-PGDS… | 5 mg | 33261-5 | More Info |
| TAS 301 | An inhibitor of Ca2+ mobilization, CaM kinase II activation (10 µM);… | 1 mg | 14976-1 | More Info |
| TAS 301 | An inhibitor of Ca2+ mobilization, CaM kinase II activation (10 µM);… | 10 mg | 14976-10 | More Info |
| TAS 301 | An inhibitor of Ca2+ mobilization, CaM kinase II activation (10 µM);… | 5 mg | 14976-5 | More Info |
| TAS 6417 | A pan-EGFR inhibitor; inhibits wild-type EGFR (IC50 = 8 nM), as well as EG… | 10 mg | 27911-10 | More Info |
| TAS 6417 | A pan-EGFR inhibitor; inhibits wild-type EGFR (IC50 = 8 nM), as well as EG… | 25 mg | 27911-25 | More Info |
| TAS 6417 | A pan-EGFR inhibitor; inhibits wild-type EGFR (IC50 = 8 nM), as well as EG… | 5 mg | 27911-5 | More Info |
| TAS 6417 | A pan-EGFR inhibitor; inhibits wild-type EGFR (IC50 = 8 nM), as well as EG… | 50 mg | 27911-50 | More Info |
| TAS 103 (hydrochloride) | A DNA topoisomerase I and II inhibitor (IC50s = 2 and 6.5 µM, respec… | 10 mg | 29869-10 | More Info |
| TAS 103 (hydrochloride) | A DNA topoisomerase I and II inhibitor (IC50s = 2 and 6.5 µM, respec… | 100 mg | 29869-100 | More Info |
| TAS 103 (hydrochloride) | A DNA topoisomerase I and II inhibitor (IC50s = 2 and 6.5 µM, respec… | 25 mg | 29869-25 | More Info |
| TAS 103 (hydrochloride) | A DNA topoisomerase I and II inhibitor (IC50s = 2 and 6.5 µM, respec… | 50 mg | 29869-50 | More Info |
| Tasimelteon | An MT receptor antagonist (Kis = 0.304 and 0.069 nM for MT1 and MT2, respe… | 10 mg | 23546-10 | More Info |
| Tasimelteon | An MT receptor antagonist (Kis = 0.304 and 0.069 nM for MT1 and MT2, respe… | 25 mg | 23546-25 | More Info |
| Tasimelteon | An MT receptor antagonist (Kis = 0.304 and 0.069 nM for MT1 and MT2, respe… | 5 mg | 23546-5 | More Info |
| Tasimelteon | An MT receptor antagonist (Kis = 0.304 and 0.069 nM for MT1 and MT2, respe… | 50 mg | 23546-50 | More Info |
| Tasimelteon-d5 | An internal standard for the quantification of tasimelteon by GC- or LC-MS | 1 mg | 31771-1 | More Info |
| Tasimelteon-d5 | An internal standard for the quantification of tasimelteon by GC- or LC-MS | 5 mg | 31771-5 | More Info |
| TASIN-1 | A small molecule inhibitor that specifically kills cells with APC (IC50 =… | 1 mg | 21155-1 | More Info |
| TASIN-1 | A small molecule inhibitor that specifically kills cells with APC (IC50 =… | 500 µg | 21155-500 | More Info |
| Tasisulam | An anticancer agent; inhibits the growth of Calu-6 NSCLC and A-375 melanom… | 10 mg | 21556-10 | More Info |
| Tasisulam | An anticancer agent; inhibits the growth of Calu-6 NSCLC and A-375 melanom… | 25 mg | 21556-25 | More Info |
| Tasisulam | An anticancer agent; inhibits the growth of Calu-6 NSCLC and A-375 melanom… | 5 mg | 21556-5 | More Info |
| Tasisulam | An anticancer agent; inhibits the growth of Calu-6 NSCLC and A-375 melanom… | 50 mg | 21556-50 | More Info |
| TAS 115 (methanesulfonate) | A multi-kinase inhibitor; an inhibitor of PDGFRα and PDGFRβ (IC… | 1 mg | 33593-1 | More Info |
| TAS 115 (methanesulfonate) | A multi-kinase inhibitor; an inhibitor of PDGFRα and PDGFRβ (IC… | 10 mg | 33593-10 | More Info |
| TAS 115 (methanesulfonate) | A multi-kinase inhibitor; an inhibitor of PDGFRα and PDGFRβ (IC… | 25 mg | 33593-25 | More Info |
| TAS 115 (methanesulfonate) | A multi-kinase inhibitor; an inhibitor of PDGFRα and PDGFRβ (IC… | 5 mg | 33593-5 | More Info |
| Tasosartan | An AT2 receptor antagonist (IC50 = 1.2 nM in rat adrenal gland membranes);… | 100 mg | 29495-100 | More Info |
| Tasosartan | An AT2 receptor antagonist (IC50 = 1.2 nM in rat adrenal gland membranes);… | 25 mg | 29495-25 | More Info |
| Tasosartan | An AT2 receptor antagonist (IC50 = 1.2 nM in rat adrenal gland membranes);… | 250 mg | 29495-250 | More Info |
| Tasosartan | An AT2 receptor antagonist (IC50 = 1.2 nM in rat adrenal gland membranes);… | 50 mg | 29495-50 | More Info |
| Tasquinimod | An orally-active quinoline-3-carboxamide that inhibits tumor angiogenesis… | 1 mg | 17692-1 | More Info |
| Tasquinimod | An orally-active quinoline-3-carboxamide that inhibits tumor angiogenesis… | 10 mg | 17692-10 | More Info |
| Tasquinimod | An orally-active quinoline-3-carboxamide that inhibits tumor angiogenesis… | 25 mg | 17692-25 | More Info |
| Tasquinimod | An orally-active quinoline-3-carboxamide that inhibits tumor angiogenesis… | 5 mg | 17692-5 | More Info |
| Tat-AKAP79 (326-336) (trifluoroacetate salt) | A peptide; inhibits PKA or PKC activation-induced sensitization of TRPV1 i… | 1 mg | 37444-1 | More Info |
| Tat-AKAP79 (326-336) (trifluoroacetate salt) | A peptide; inhibits PKA or PKC activation-induced sensitization of TRPV1 i… | 10 mg | 37444-10 | More Info |
| Tat-AKAP79 (326-336) (trifluoroacetate salt) | A peptide; inhibits PKA or PKC activation-induced sensitization of TRPV1 i… | 25 mg | 37444-25 | More Info |
| Tat-AKAP79 (326-336) (trifluoroacetate salt) | A peptide; inhibits PKA or PKC activation-induced sensitization of TRPV1 i… | 5 mg | 37444-5 | More Info |
| Tat-ASIC1a (1-20) (mouse, rat) (trifluoroacetate salt) | A peptide; prevents acid-induced association of the complex between ASIC1a… | 1 mg | 37501-1 | More Info |
| Tat-ASIC1a (1-20) (mouse, rat) (trifluoroacetate salt) | A peptide; prevents acid-induced association of the complex between ASIC1a… | 10 mg | 37501-10 | More Info |
| Tat-ASIC1a (1-20) (mouse, rat) (trifluoroacetate salt) | A peptide; prevents acid-induced association of the complex between ASIC1a… | 5 mg | 37501-5 | More Info |
| Tat-Beclin 1 (acetate) | An autophagy-inducing peptide; binds to GAPR-1 in HeLa cells and induces c… | 1 mg | 35838-1 | More Info |
| Tat-Beclin 1 (acetate) | An autophagy-inducing peptide; binds to GAPR-1 in HeLa cells and induces c… | 10 mg | 35838-10 | More Info |
| Tat-Beclin 1 (acetate) | An autophagy-inducing peptide; binds to GAPR-1 in HeLa cells and induces c… | 25 mg | 35838-25 | More Info |
| Tat-Beclin 1 (acetate) | An autophagy-inducing peptide; binds to GAPR-1 in HeLa cells and induces c… | 5 mg | 35838-5 | More Info |
| Tat-βsyn-degron (trifluoroacetate salt) | An α-synuclein knockdown peptide; binds to recombinant α-synuc… | 1 mg | 37442-1 | More Info |
| Tat-βsyn-degron (trifluoroacetate salt) | An α-synuclein knockdown peptide; binds to recombinant α-synuc… | 10 mg | 37442-10 | More Info |
| Tat-βsyn-degron (trifluoroacetate salt) | An α-synuclein knockdown peptide; binds to recombinant α-synuc… | 25 mg | 37442-25 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile